Global Retirement Partners LLC raised its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 71.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 15,177 shares of the financial services provider’s stock after buying an additional 6,306 shares during the quarter. Global Retirement Partners LLC’s holdings in CME Group were worth $4,145,000 at the end of the most recent reporting period.
Other hedge funds have also added to or reduced their stakes in the company. Asset Dedication LLC grew its holdings in CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 37 shares in the last quarter. FNY Investment Advisers LLC purchased a new position in CME Group during the 4th quarter valued at about $27,000. Legacy Wealth Managment LLC ID boosted its position in shares of CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 71 shares during the last quarter. Global Wealth Strategies & Associates boosted its position in shares of CME Group by 1,250.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 100 shares during the last quarter. Finally, Anfield Capital Management LLC boosted its position in shares of CME Group by 197.4% during the 4th quarter. Anfield Capital Management LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after acquiring an additional 75 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.
CME Group Stock Performance
NASDAQ CME opened at $289.29 on Friday. The company has a 50-day simple moving average of $296.62 and a two-hundred day simple moving average of $289.10. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12-month low of $257.17 and a 12-month high of $329.16. The firm has a market cap of $104.83 billion, a price-to-earnings ratio of 24.68, a PEG ratio of 3.51 and a beta of 0.23.
CME Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be given a $1.30 dividend. The ex-dividend date is Tuesday, June 9th. This represents a $5.20 annualized dividend and a yield of 1.8%. CME Group’s payout ratio is presently 44.37%.
Insider Buying and Selling
In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the sale, the chief executive officer owned 55,630 shares in the company, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares of the company’s stock, valued at $8,438,860.26. The trade was a 17.20% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 48,244 shares of company stock worth $14,598,037. Company insiders own 0.30% of the company’s stock.
Analysts Set New Price Targets
A number of analysts have recently issued reports on the company. Morgan Stanley dropped their price target on CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a research report on Thursday, April 23rd. Rothschild & Co Redburn dropped their price target on CME Group from $340.00 to $316.00 and set a “neutral” rating for the company in a research report on Monday, April 27th. Wall Street Zen downgraded CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, April 26th. Raymond James Financial lifted their price target on CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a research report on Monday, April 6th. Finally, JPMorgan Chase & Co. lifted their price target on CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a research report on Thursday, April 16th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $305.29.
Read Our Latest Stock Report on CME Group
CME Group Company Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Stories
- Five stocks we like better than CME Group
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
